Australian researchers discover 101 genetic regions linked to cataract risk
QIMR Berghofer researchers have made a groundbreaking discovery in the largest ever genetic study on cataracts, analyzing the ...
Business Wire2d
Trace Neuroscience Launches With $101 Million Series A Financing to Expand Genomic Medicine for Neurodegenerative Diseases
Trace Neuroscience Launches with $101 Million Series A Financing to Expand Genomic Medicine for Neurodegenerative Diseases, ...
FierceBiotech2d
Third Rock-backed Trace uses $101M series A to go after same ALS target as Lilly
Almost all cases of ALS and half of frontotemporal dementia (FTD) cases are linked to dysfunction in a protein TDP-43.
health.economictimes.indiatimes1h
India's Diabetes Crisis: Comprehensive Strategies for Prevention and Early Intervention
The scale of this challenge is staggering - nearly 101 million adults in India are already living with type 2 diabetes. Type ...
BioPharma Dive1d
Biotech investors, including Third Rock, pump $100M into a startup’s genetic medicine for ALS
Trace Neuroscience aims to advance an RNA-binding therapy designed to preserve — and potentially improve — muscle function in ...
GlobalData on MSN22h
Syndax’s stock sinks by 25% despite AML trial meeting primary endpoint
Despite this success, investors were unimpressed with the topline data, with Syndax’s stock dropping by 25.6%, from $21.78 ...
STAT2d
Fueled by a ‘fall off your chair’ discovery and $101 million, Trace launches to take on ALS
Trace Neuroscience launched on Tuesday to announce that it is developing a genetic treatment targeting UNC13A, a gene linked ...
Dyne Therapeutics' Q3 Preview: High-Risk, High-Reward Path In Muscle Diseases
Investors consider Dyne Therapeutics' treatments for muscle diseases and strong cash position as a speculative Buy ...
The Pharma Letter1d
Syndax shares slide despite pivotal trial success
Syndax Pharmaceuticals (Nasdaq: SNDX) has announced that its Phase II AUGMENT-101 trial of experimental drug revumenib ...
Italy wants to help you discover your roots—and meet distant relatives
This writer traced her roots back to a small Calabrian village and found 100 living relatives. A new Italian initiative makes ...
pharmaphorum7h
Metsera gets $215m for obesity trials, and other financings
The sizeable new round follows the announcement of phase 1 data for its lead asset MET-097i in September, and according to ...
Finanznachrichten2d
Trace Neuroscience, Inc.: Trace Neuroscience Launches With $101 Million Series A Financing to Expand Genomic Medicine for Neurodegenerative Diseases
"UNC13A is a highly compelling genetic target directly linked to ALS disease progression and survival. Insights from the human genome have led to transformative medicines for many diseases, and with ...